{
  "DOI": "10.1038/ejhg.2012.273",
  "ISSN": [
    "1018-4813",
    "1476-5438"
  ],
  "URL": "http://dx.doi.org/10.1038/ejhg.2012.273",
  "alternative-id": [
    "BFejhg2012273"
  ],
  "author": [
    {
      "affiliation": [],
      "family": "Danza",
      "given": "K",
      "sequence": "first"
    },
    {
      "affiliation": [],
      "family": "Pilato",
      "given": "B",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Lacalamita",
      "given": "R",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Addati",
      "given": "T",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Giotta",
      "given": "F",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Bruno",
      "given": "A",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Paradiso",
      "given": "A",
      "sequence": "additional"
    },
    {
      "affiliation": [],
      "family": "Tommasi",
      "given": "S",
      "sequence": "additional"
    }
  ],
  "container-title": [
    "European Journal of Human Genetics"
  ],
  "content-domain": {
    "crossmark-restriction": false,
    "domain": []
  },
  "created": {
    "date-parts": [
      [
        2012,
        12,
        12
      ]
    ],
    "date-time": "2012-12-12T11:37:36Z",
    "timestamp": 1355312256000
  },
  "deposited": {
    "date-parts": [
      [
        2023,
        5,
        18
      ]
    ],
    "date-time": "2023-05-18T17:07:05Z",
    "timestamp": 1684429625000
  },
  "indexed": {
    "date-parts": [
      [
        2024,
        2,
        11
      ]
    ],
    "date-time": "2024-02-11T21:57:18Z",
    "timestamp": 1707688638328
  },
  "is-referenced-by-count": 31,
  "issn-type": [
    {
      "type": "print",
      "value": "1018-4813"
    },
    {
      "type": "electronic",
      "value": "1476-5438"
    }
  ],
  "issue": "8",
  "issued": {
    "date-parts": [
      [
        2012,
        12,
        12
      ]
    ]
  },
  "journal-issue": {
    "issue": "8",
    "published-print": {
      "date-parts": [
        [
          2013,
          8
        ]
      ]
    }
  },
  "language": "en",
  "license": [
    {
      "URL": "http://www.springer.com/tdm",
      "content-version": "tdm",
      "delay-in-days": 0,
      "start": {
        "date-parts": [
          [
            2012,
            12,
            12
          ]
        ],
        "date-time": "2012-12-12T00:00:00Z",
        "timestamp": 1355270400000
      }
    }
  ],
  "link": [
    {
      "URL": "http://www.nature.com/articles/ejhg2012273.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2012273",
      "content-type": "text/html",
      "content-version": "vor",
      "intended-application": "text-mining"
    },
    {
      "URL": "http://www.nature.com/articles/ejhg2012273.pdf",
      "content-type": "application/pdf",
      "content-version": "vor",
      "intended-application": "similarity-checking"
    }
  ],
  "member": "297",
  "page": "824-830",
  "prefix": "10.1038",
  "published": {
    "date-parts": [
      [
        2012,
        12,
        12
      ]
    ]
  },
  "published-online": {
    "date-parts": [
      [
        2012,
        12,
        12
      ]
    ]
  },
  "published-print": {
    "date-parts": [
      [
        2013,
        8
      ]
    ]
  },
  "publisher": "Springer Science and Business Media LLC",
  "reference": [
    {
      "DOI": "10.1038/35025215",
      "author": "GD Yancopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "242",
      "journal-title": "Nature",
      "key": "BFejhg2012273_CR1",
      "unstructured": "Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J : Vascular-specific growth factors and blood vessel formation. Nature 2000; 407: 242–248.",
      "volume": "407",
      "year": "2000"
    },
    {
      "DOI": "10.1002/cncr.26540",
      "author": "SE Abdullah",
      "doi-asserted-by": "publisher",
      "first-page": "3455",
      "journal-title": "Cancer",
      "key": "BFejhg2012273_CR2",
      "unstructured": "Abdullah SE, Perez-Soler R : Mechanisms of resistance to vascular endothelial growth factor blockade. Cancer 2011; 118: 3455–3467.",
      "volume": "118",
      "year": "2011"
    },
    {
      "DOI": "10.1038/nrc2894",
      "author": "H Huang",
      "doi-asserted-by": "publisher",
      "first-page": "575",
      "journal-title": "Nat Rev Cancer",
      "key": "BFejhg2012273_CR3",
      "unstructured": "Huang H, Bhat A, Woodnutt G, Lappe R : Targeting the ANGPT-TIE2 pathway in malignancy. Nat Rev Cancer 2010; 10: 575–585.",
      "volume": "10",
      "year": "2010"
    },
    {
      "author": "S Fukuhara",
      "first-page": "387",
      "journal-title": "Histol Histopathol",
      "key": "BFejhg2012273_CR4",
      "unstructured": "Fukuhara S, Sako K, Noda K, Zhang J, Minami M, Mochizuki N : Angiopoietin-1/Tie2 receptor signaling in vascular quiescence and angiogenesis. Histol Histopathol 2010; 25: 387–396.",
      "volume": "25",
      "year": "2010"
    },
    {
      "DOI": "10.1111/j.1365-2559.2011.03920.x",
      "author": "CA Staton",
      "doi-asserted-by": "publisher",
      "first-page": "256",
      "journal-title": "Histopathology",
      "key": "BFejhg2012273_CR5",
      "unstructured": "Staton CA, Hoh L, Baldwin A et al: Angiopoietins 1 and 2 and Tie-2 receptor expression in human ductal breast disease. Histopathology 2011; 59: 256–263.",
      "volume": "59",
      "year": "2011"
    },
    {
      "DOI": "10.1007/s10549-005-9157-9",
      "author": "S Tsutsui",
      "doi-asserted-by": "publisher",
      "first-page": "261",
      "journal-title": "Breast Cancer Res Treat",
      "key": "BFejhg2012273_CR6",
      "unstructured": "Tsutsui S, Inoue H, Yasuda K et al: Angiopoietin 2 expression in invasive ductal carcinoma of the breast: its relationship to the VEGF expression and microvessel density. Breast Cancer Res Treat 2006; 98: 261–266.",
      "volume": "98",
      "year": "2006"
    },
    {
      "DOI": "10.1016/j.biocel.2009.11.020",
      "author": "A Vassilopoulos",
      "doi-asserted-by": "publisher",
      "first-page": "193",
      "journal-title": "Int J Biochem Cell Biol",
      "key": "BFejhg2012273_CR7",
      "unstructured": "Vassilopoulos A, Deng CX, Chavakis T : Crosstalk between the DNA damage response, histone modifications and neovascularisation. Int J Biochem Cell Biol 2010; 42: 193–197.",
      "volume": "42",
      "year": "2010"
    },
    {
      "DOI": "10.1038/sj.onc.1205971",
      "author": "H Kawai",
      "doi-asserted-by": "publisher",
      "first-page": "7730",
      "journal-title": "Oncogene",
      "key": "BFejhg2012273_CR8",
      "unstructured": "Kawai H, Li H, Chun P, Avraham S, Avraham HK : Direct interaction between BRCA1 and the estrogen receptor regulates vascular endothelial growth factor (VEGF) transcription and secretion in breast cancer cells. Oncogene 2002; 21: 7730–7739.",
      "volume": "21",
      "year": "2002"
    },
    {
      "DOI": "10.1016/j.ccr.2006.05.022",
      "author": "S Furuta",
      "doi-asserted-by": "publisher",
      "first-page": "13",
      "journal-title": "Cancer Cell",
      "key": "BFejhg2012273_CR9",
      "unstructured": "Furuta S, Wang JM, Wei S et al: Removal of BRCA1/CtIP/ZBRK1 repressor complex on ANG1 promoter leads to accelerated mammary tumor growth contributed by prominent vasculature. Cancer Cell 2006; 10: 13–24.",
      "volume": "10",
      "year": "2006"
    },
    {
      "DOI": "10.1177/145749690209100312",
      "author": "H Eerola",
      "doi-asserted-by": "publisher",
      "first-page": "280",
      "journal-title": "Scand J Surg",
      "key": "BFejhg2012273_CR10",
      "unstructured": "Eerola H, Aittomaki K, Asko-Seljavaara S, Nevanlinna H, von Smitten K : Hereditary breast cancer and handling of patients at risk. Scand J Surg 2002; 91: 280–287.",
      "volume": "91",
      "year": "2002"
    },
    {
      "DOI": "10.1186/1471-2407-10-145",
      "author": "MR Heerma van Voss",
      "doi-asserted-by": "publisher",
      "first-page": "145",
      "journal-title": "BMC Cancer",
      "key": "BFejhg2012273_CR11",
      "unstructured": "Heerma van Voss MR, van der Groep P, Bart J, van der Wall E, van Diest PJ : Lympho-vascular invasion in BRCA related breast cancer compared to sporadic controls. BMC Cancer 2010; 10: 145.",
      "volume": "10",
      "year": "2010"
    },
    {
      "DOI": "10.5306/wjco.v2.i9.329",
      "author": "JD Davis",
      "doi-asserted-by": "publisher",
      "first-page": "329",
      "journal-title": "World J Clin Oncol",
      "key": "BFejhg2012273_CR12",
      "unstructured": "Davis JD, Lin SY : DNA damage and breast cancer. World J Clin Oncol 2011; 2: 329–338.",
      "volume": "2",
      "year": "2011"
    },
    {
      "DOI": "10.1016/j.mrfmmm.2005.06.010",
      "author": "S Tommasi",
      "doi-asserted-by": "publisher",
      "first-page": "395",
      "journal-title": "Mutat Res",
      "key": "BFejhg2012273_CR13",
      "unstructured": "Tommasi S, Crapolicchio A, Lacalamita R et al: BRCA1 mutations and polymorphisms in a hospital-based consecutive series of breast cancer patients from Apulia, Italy. Mutat Res 2005; 578: 395–405.",
      "volume": "578",
      "year": "2005"
    },
    {
      "DOI": "10.1387/ijdb.103212rm",
      "author": "R Munoz-Chapuli",
      "doi-asserted-by": "publisher",
      "first-page": "345",
      "journal-title": "Int J Dev Biol",
      "key": "BFejhg2012273_CR14",
      "unstructured": "Munoz-Chapuli R : Evolution of angiogenesis. Int J Dev Biol 2011; 55: 345–351.",
      "volume": "55",
      "year": "2011"
    },
    {
      "DOI": "10.1074/jbc.M513033200",
      "author": "HJ Kang",
      "doi-asserted-by": "publisher",
      "first-page": "13047",
      "journal-title": "J Biol Chem",
      "key": "BFejhg2012273_CR15",
      "unstructured": "Kang HJ, Kim HJ, Rih JK et al: BRCA1 plays a role in the hypoxic response by regulating HIF-1alpha stability and by modulating vascular endothelial growth factor expression. J Biol Chem 2006; 281: 13047–13056.",
      "volume": "281",
      "year": "2006"
    },
    {
      "DOI": "10.1038/sj.bjc.6605287",
      "author": "M Yan",
      "doi-asserted-by": "publisher",
      "first-page": "1168",
      "journal-title": "Br J Cancer",
      "key": "BFejhg2012273_CR16",
      "unstructured": "Yan M, Rayoo M, Takano EA, Fox SB : BRCA1 tumours correlate with a HIF-1alpha phenotype and have a poor prognosis through modulation of hydroxylase enzyme profile expression. Br J Cancer 2009; 101: 1168–1174.",
      "volume": "101",
      "year": "2009"
    },
    {
      "author": "L Zhang",
      "first-page": "3403",
      "journal-title": "Cancer Res",
      "key": "BFejhg2012273_CR17",
      "unstructured": "Zhang L, Yang N, Park JW et al: Tumor-derived vascular endothelial growth factor up-regulates angiopoietin-2 in host endothelium and destabilizes host vasculature, supporting angiogenesis in ovarian cancer. Cancer Res 2003; 63: 3403–3412.",
      "volume": "63",
      "year": "2003"
    },
    {
      "DOI": "10.1097/01.MP.0000071841.17900.69",
      "author": "WS Moon",
      "doi-asserted-by": "publisher",
      "first-page": "552",
      "journal-title": "Mod Pathol",
      "key": "BFejhg2012273_CR18",
      "unstructured": "Moon WS, Rhyu KH, Kang MJ et al: Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Mod Pathol 2003; 16: 552–557.",
      "volume": "16",
      "year": "2003"
    },
    {
      "DOI": "10.3748/wjg.v10.i9.1382",
      "author": "XD Sun",
      "doi-asserted-by": "publisher",
      "first-page": "1382",
      "journal-title": "World J Gastroenterol",
      "key": "BFejhg2012273_CR19",
      "unstructured": "Sun XD, Liu XE, Wu JM, Cai XJ, Mou YP, Li JD : Expression and significance of angiopoietin-2 in gastric cancer. World J Gastroenterol 2004; 10: 1382–1385.",
      "volume": "10",
      "year": "2004"
    },
    {
      "DOI": "10.1038/sj.cr.7290176",
      "author": "LJ Metheny-Barlow",
      "doi-asserted-by": "publisher",
      "first-page": "309",
      "journal-title": "Cell Res",
      "key": "BFejhg2012273_CR20",
      "unstructured": "Metheny-Barlow LJ, Li LY : The enigmatic role of angiopoietin-1 in tumor angiogenesis. Cell Res 2003; 13: 309–317.",
      "volume": "13",
      "year": "2003"
    },
    {
      "DOI": "10.1126/science.277.5322.55",
      "author": "PC Maisonpierre",
      "doi-asserted-by": "publisher",
      "first-page": "55",
      "journal-title": "Science",
      "key": "BFejhg2012273_CR21",
      "unstructured": "Maisonpierre PC, Suri C, Jones PF et al: Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis. Science 1997; 277: 55–60.",
      "volume": "277",
      "year": "1997"
    },
    {
      "DOI": "10.1038/nrm2639",
      "author": "HG Augustin",
      "doi-asserted-by": "publisher",
      "first-page": "165",
      "journal-title": "Nat Rev Mol Cell Biol",
      "key": "BFejhg2012273_CR22",
      "unstructured": "Augustin HG, Koh GY, Thurston G, Alitalo K : Control of vascular morphogenesis and homeostasis through the angiopoietin-Tie system. Nat Rev Mol Cell Biol 2009; 10: 165–177.",
      "volume": "10",
      "year": "2009"
    },
    {
      "DOI": "10.1634/theoncologist.2011-S1-61",
      "author": "CM Perou",
      "doi-asserted-by": "publisher",
      "first-page": "61",
      "issue": "Suppl 1",
      "journal-title": "Oncologist",
      "key": "BFejhg2012273_CR23",
      "unstructured": "Perou CM : Molecular stratification of triple-negative breast cancers. Oncologist 2011; 16 (Suppl 1): 61–70.",
      "volume": "16",
      "year": "2011"
    },
    {
      "DOI": "10.1093/annonc/mdp062",
      "author": "BK Linderholm",
      "doi-asserted-by": "publisher",
      "first-page": "1639",
      "journal-title": "Ann Oncol",
      "key": "BFejhg2012273_CR24",
      "unstructured": "Linderholm BK, Hellborg H, Johansson U et al: Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer. Ann Oncol 2009; 20: 1639–1646.",
      "volume": "20",
      "year": "2009"
    },
    {
      "DOI": "10.3324/haematol.11852",
      "author": "K Anargyrou",
      "doi-asserted-by": "publisher",
      "first-page": "451",
      "journal-title": "Haematologica",
      "key": "BFejhg2012273_CR25",
      "unstructured": "Anargyrou K, Terpos E, Vassilakopoulos TP et al: Normalization of the serum angiopoietin-1 to angiopoietin-2 ratio reflects response in refractory/resistant multiple myeloma patients treated with bortezomib. Haematologica 2008; 93: 451–454.",
      "volume": "93",
      "year": "2008"
    },
    {
      "DOI": "10.1002/pros.20163",
      "author": "AJ Lind",
      "doi-asserted-by": "publisher",
      "first-page": "394",
      "journal-title": "Prostate",
      "key": "BFejhg2012273_CR26",
      "unstructured": "Lind AJ, Wikstrom P, Granfors T, Egevad L, Stattin P, Bergh A : Angiopoietin 2 expression is related to histological grade, vascular density, metastases, and outcome in prostate cancer. Prostate 2005; 62: 394–399.",
      "volume": "62",
      "year": "2005"
    },
    {
      "DOI": "10.1182/blood-2009-11-252494",
      "author": "R Maffei",
      "doi-asserted-by": "publisher",
      "first-page": "584",
      "journal-title": "Blood",
      "key": "BFejhg2012273_CR27",
      "unstructured": "Maffei R, Martinelli S, Santachiara R et al: Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia. Blood 2010; 116: 584–592.",
      "volume": "116",
      "year": "2010"
    },
    {
      "DOI": "10.1002/ijc.10851",
      "author": "C Sfiligoi",
      "doi-asserted-by": "publisher",
      "first-page": "466",
      "journal-title": "Int J Cancer",
      "key": "BFejhg2012273_CR28",
      "unstructured": "Sfiligoi C, de Luca A, Cascone I et al: Angiopoietin-2 expression in breast cancer correlates with lymph node invasion and short survival. Int J Cancer 2003; 103: 466–474.",
      "volume": "103",
      "year": "2003"
    },
    {
      "DOI": "10.1186/1477-7800-4-6",
      "author": "KA Rmali",
      "doi-asserted-by": "publisher",
      "first-page": "6",
      "journal-title": "Int Semin Surg Oncol",
      "key": "BFejhg2012273_CR29",
      "unstructured": "Rmali KA, Watkins G, Douglas-Jones A, Mansel RE, Jiang WG : Angiopoietins lack of prognostic significance in ductal mammary carcinoma. Int Semin Surg Oncol 2007; 4: 6.",
      "volume": "4",
      "year": "2007"
    },
    {
      "author": "SH Ali",
      "first-page": "7094",
      "journal-title": "Cancer Res",
      "key": "BFejhg2012273_CR30",
      "unstructured": "Ali SH, O'Donnell AL, Balu D et al: Estrogen receptor-alpha in the inhibition of cancer growth and angiogenesis. Cancer Res 2000; 60: 7094–7098.",
      "volume": "60",
      "year": "2000"
    }
  ],
  "reference-count": 30,
  "references-count": 30,
  "resource": {
    "primary": {
      "URL": "https://www.nature.com/articles/ejhg2012273"
    }
  },
  "score": 0,
  "short-container-title": [
    "Eur J Hum Genet"
  ],
  "source": "Crossref",
  "title": [
    "Angiogenetic axis angiopoietins/Tie2 and VEGF in familial breast cancer"
  ],
  "type": "journal-article",
  "volume": "21"
}